SNDL（VY4）株式概要SNDL Inc.はカナダで大麻製品の製造、流通、販売に従事している。 詳細VY4 ファンダメンタル分析スノーフレーク・スコア評価3/6将来の成長0/6過去の実績0/6財務の健全性6/6配当金0/6報酬過去5年間の収益は年間28.6%増加しました。 同業他社や業界と比較して、良好な取引価格 リスク分析現在は利益が出ておらず、今後3年間で利益が出る見込みはない すべてのリスクチェックを見るVY4 Community Fair Values Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.Your Fair Value€Current Price€1.2280.7% 割安 内在価値ディスカウントGrowth estimate overAnnual revenue growth rate5 Yearstime period%/yrDecreaseIncreasePastFuture-331m1b2016201920222025202620282031Revenue CA$1.1bEarnings CA$164.9mAdvancedSet Fair ValueView all narrativesSNDL Inc. 競合他社PEPTONIC medicalSymbol: DB:28LMarket cap: €560.2mCantourage GroupSymbol: XTRA:HIGHMarket cap: €75.1mDermapharm HoldingSymbol: XTRA:DMPMarket cap: €2.4bBiofronteraSymbol: XTRA:B8FKMarket cap: €14.7m価格と性能株価の高値、安値、推移の概要SNDL過去の株価現在の株価US$1.2252週高値US$2.4152週安値US$1.00ベータ0.881ヶ月の変化-6.66%3ヶ月変化-7.58%1年変化6.09%3年間の変化-15.40%5年間の変化-82.49%IPOからの変化-98.25%最新ニュースBoard Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director James Cannell was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 16SNDL Inc. to Report Q1, 2026 Results on Apr 29, 2026SNDL Inc. announced that they will report Q1, 2026 results Pre-Market on Apr 29, 2026お知らせ • Mar 31SNDL Inc. Announces Executive Changes for Cannabis SegmentSNDL Inc. announced on March 30, 2026 that Tyler Robson, President of Cannabis, has left the Company in order to pursue other opportunities. Ryan Hellard, SNDL’s current Chief Strategy Officer, will assume the role of Interim President of Cannabis. The Company wishes Mr. Robson success in his future endeavours.お知らせ • Feb 20SNDL Inc. to Report Q4, 2025 Results on Mar 12, 2026SNDL Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026お知らせ • Nov 22SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 24,500,000 shares, for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 24,500,000 common shares, representing 10% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2026.お知らせ • Oct 16SNDL Inc. to Report Q3, 2025 Results on Nov 04, 2025SNDL Inc. announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 04, 2025最新情報をもっと見るRecent updatesBoard Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director James Cannell was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.お知らせ • Apr 16SNDL Inc. to Report Q1, 2026 Results on Apr 29, 2026SNDL Inc. announced that they will report Q1, 2026 results Pre-Market on Apr 29, 2026お知らせ • Mar 31SNDL Inc. Announces Executive Changes for Cannabis SegmentSNDL Inc. announced on March 30, 2026 that Tyler Robson, President of Cannabis, has left the Company in order to pursue other opportunities. Ryan Hellard, SNDL’s current Chief Strategy Officer, will assume the role of Interim President of Cannabis. The Company wishes Mr. Robson success in his future endeavours.お知らせ • Feb 20SNDL Inc. to Report Q4, 2025 Results on Mar 12, 2026SNDL Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026お知らせ • Nov 22SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 24,500,000 shares, for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 24,500,000 common shares, representing 10% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2026.お知らせ • Oct 16SNDL Inc. to Report Q3, 2025 Results on Nov 04, 2025SNDL Inc. announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 04, 2025お知らせ • Jul 11SNDL Inc. to Report Q2, 2025 Results on Jul 31, 2025SNDL Inc. announced that they will report Q2, 2025 results Pre-Market on Jul 31, 2025お知らせ • Jun 23SNDL Inc., Annual General Meeting, Jul 29, 2025SNDL Inc., Annual General Meeting, Jul 29, 2025.お知らせ • Apr 15SNDL Inc. to Report Q1, 2025 Results on May 01, 2025SNDL Inc. announced that they will report Q1, 2025 results Pre-Market on May 01, 2025お知らせ • Feb 26SNDL Inc. to Report Q4, 2024 Results on Mar 18, 2025SNDL Inc. announced that they will report Q4, 2024 results at 9:30 AM, US Eastern Standard Time on Mar 18, 2025お知らせ • Nov 22SNDL Inc. Announces Executive AppointmentsSNDL Inc. announced the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. Phil McBride joins SNDL with more than 25 years of experience across consumer-packaged goods, financial services and retail industries, having held leadership roles at OMERS, Molson Coors, Aeroplan, and Proctor & Gamble. His demonstrated capabilities include digital transformation, data analytics advancement, the integration of generative AI technologies, and stewardship of one of Canada's most successful loyalty programs. Navroop Sandhawalia, who joined SNDL in October 2023 as Vice President of Finance, and was promoted to Interim President, Liquor Division in September, has made significant contributions to performance management and operational efficiency, driving improved decision-making across the liquor business. His experience includes over 13 years at Loblaws where he held various roles within finance, analytics and data science.お知らせ • Nov 15SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,200,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 13,200,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2025.お知らせ • Nov 06SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H).SNDL Inc. (NasdaqCM:SNDL) enters into a stalking horse purchase agreement to acquire a remaining majority stake in Indiva Limited (TSXV:NDVA.H) for CAD 22.7 million on July 5, 2024. PricewaterhouseCoopers Inc. (The Monitor) currently estimates the value of the credit bid and cash consideration payable by SNDL under the Bid Agreement to be in the range of approximately CAD 25 million to CAD 28 million. As of July 8, 2024, the Court has approved the sale process. The Transaction is anticipated to close during SNDL's fourth quarter following the receipt of all such approvals. Indiva will seek approval for the Transaction from the Court on or about September 19, 2024. As per filing on August 29, 2024, stalking horse bid of SNDL has been chosen as the successful bid in the acquisition of Indiva. McCarthy Tétrault LLP is acting as legal counsel for SNDL, Bennett Jones LLP is acting as legal counsel for the Indiva Group, and Osler Hoskin & Harcourt LLP is acting as legal counsel for PricewaterhouseCoopers Inc. (the monitor). SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H) on November 4, 2024.お知らせ • Oct 25SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024SNDL Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 05, 2024お知らせ • Oct 22SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.4 million on August 12, 2024. Under the terms of the Agreement, Nova's shareholders will receive CAD 1.75 in cash for each Nova Share. Nova shareholders also have the ability to elect to receive, in lieu of the Cash Consideration, 0.58 of a common share of SNDL for each Nova Share, subject to proration and a maximum of 50% of the aggregate Consideration being payable in SNDL Shares. The Agreement also provides for the payment of a termination fee of CAD 800,000 payable to SNDL by Nova in the event the Transaction is terminated in certain specified circumstances. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada. The transaction is subject to Key Regulatory Approvals. The Transaction has been approved by the boards of directors of both SNDL and Nova. As of October 16, 2024, The Transaction has been approved by Nova shareholders. The Transaction is expected to close on or before October 18, 2024. Ranjeev Dhillon and Rami Chalabi of McCarthy Tétrault LLP is acting as legal counsel to SNDL. Eight Capital is acting as financial advisor and Jon Truswel of Bennett Jones LLP is acting as legal counsel to Nova. Eight Capital Inc. acted as fairness opinion provider to Nova. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) on October 21, 2024. In connection with the Arrangement, SNDL intends to appoint to its board of directors J. Carlo Cannell. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Odyssey Trust Company acted as depository to Nova Cannabis.お知らせ • Oct 21SNDL Inc. Appoints J. Carlo to Its Board of DirectorsSNDL Inc. announced that in connection with the Arrangement, SNDL intends to appoint to its board of directors J. Carlo, 61, a leading practitioner of special situations since the formation of Cannell Capital in 1992.Breakeven Date Change • Oct 16No longer forecast to breakevenThe 2 analysts covering SNDL no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$3.90m in 2025. New consensus forecast suggests the company will make a loss of CA$14.5m in 2025.お知らせ • Aug 14SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million on August 13, 2024. Under the terms of the Agreement, Nova's shareholders will receive CAD 1.75 in cash for each Nova Share. Nova shareholders also have the ability to elect to receive, in lieu of the Cash Consideration, 0.58 of a common share of SNDL for each Nova Share, subject to proration and a maximum of 50% of the aggregate Consideration being payable in SNDL Shares. The Agreement also provides for the payment of a termination fee of CAD 800,000 payable to SNDL by Nova in the event the Transaction is terminated in certain specified circumstances. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada. The Transaction has been approved by the boards of directors of both SNDL and Nova. The Transaction is expected to close on or before October 18, 2024. McCarthy Tétrault LLP is acting as legal counsel to SNDL. Eight Capital is acting as financial advisor and Bennett Jones LLP is acting as legal counsel to Nova. Eight Capital Inc. acted as fairness opinion provider to Nova.お知らせ • Jul 20SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024SNDL Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 02, 2024お知らせ • Jun 24SNDL Inc., Annual General Meeting, Jul 30, 2024SNDL Inc., Annual General Meeting, Jul 30, 2024.New Risk • May 10New major risk - Revenue and earnings growthEarnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 11% per year over the past 5 years.お知らせ • May 10SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024SNDL Inc. reported asset impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported asset impairment of $1,656,000 against $807,000 a year ago.Reported Earnings • May 09First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (improved from CA$0.13 loss in 1Q 2023). Revenue: CA$197.8m (down 2.3% from 1Q 2023). Net loss: CA$2.55m (loss narrowed 93% from 1Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.お知らせ • Apr 28SNDL Inc. to Report Q1, 2024 Results on May 09, 2024SNDL Inc. announced that they will report Q1, 2024 results Pre-Market on May 09, 2024Reported Earnings • Mar 22Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)Full year 2023 results: CA$0.67 loss per share (improved from CA$1.46 loss in FY 2022). Revenue: CA$909.0m (up 28% from FY 2022). Net loss: CA$168.1m (loss narrowed 50% from FY 2022). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Pharmaceuticals industry in Germany. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.お知らせ • Mar 02SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024SNDL Inc. announced that they will report fiscal year 2023 results Pre-Market on Mar 21, 2024Reported Earnings • Nov 14Third quarter 2023 earnings released: CA$0.08 loss per share (vs CA$0.41 loss in 3Q 2022)Third quarter 2023 results: CA$0.08 loss per share (improved from CA$0.41 loss in 3Q 2022). Revenue: CA$237.6m (up 3.1% from 3Q 2022). Net loss: CA$21.8m (loss narrowed 78% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.お知らせ • Nov 14SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 13,100,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2024.お知らせ • Oct 28SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023SNDL Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 13, 2023お知らせ • Sep 16SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and BeyondSNDL Inc. launched a new e-commerce platform for its destination liquor retail banner, Wine and Beyond. The platform aims to enhance accessibility and reach for the banner's expansive product selection, featuring rare spirits, local and international beers, and distinctive wines. Wine and Beyond's online catalogue features nearly 9,000 offerings, with fresh additions and new deals added weekly, backed by the banner's "Best Price Promise". Customers can further tailor their selections through product tasting notes and expertly curated food pairings and expand their knowledge through informed and seasonally relevant blog posts. The Company has 11 Wine and Beyond locations in Alberta and one in British Columbia, with plans to expand into Saskatchewan by 2024.Reported Earnings • Aug 15Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)Second quarter 2023 results: CA$0.12 loss per share (improved from CA$0.31 loss in 2Q 2022). Revenue: CA$244.5m (up 9.3% from 2Q 2022). Net loss: CA$29.4m (loss narrowed 60% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.お知らせ • Aug 04SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023SNDL Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 14, 2023New Risk • Jul 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (9.3% increase in shares outstanding).お知らせ • Jun 07SNDL Inc. Announces Chief Financial Officer ChangesSNDL Inc. announced the appointment of seasoned financial executive Alberto Paredero-Quiros as its new Chief Financial Officer. Mr. Paredero-Quiros brings more than 25 years of management experience in the consumer goods and pharmaceutical industries, with demonstrated leadership and financial expertise in world-class global organizations. He has held senior management roles for companies such as MondelezInternational Inc., Novartis, Newell Brands Inc., and Procter & Gamble Company, bringing extensive experience in public company reporting, mergers and acquisitions, internal controls and general financial and operational management. Mr. Paredero-Quiros' appointment will take effect on July 1, 2023. The company announced the retirement of Jim Keough for his pivotal role in building and shaping the Company for the past five years.お知らせ • May 19SNDL Inc., Annual General Meeting, Jul 27, 2023SNDL Inc., Annual General Meeting, Jul 27, 2023.お知らせ • May 10SNDL Inc. to Report Q1, 2023 Results on May 15, 2023SNDL Inc. announced that they will report Q1, 2023 results Pre-Market on May 15, 2023Breakeven Date Change • Apr 26Forecast breakeven date moved forward to 2023The analyst covering SNDL previously expected the company to break even in 2024. New forecast suggests the company will make a profit of CA$11.0m in 2023. Earnings growth of 125% is required to achieve expected profit on schedule.Breakeven Date Change • Apr 25Forecast breakeven date moved forward to 2023The 2 analysts covering SNDL previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of CA$11.0m in 2023. Earnings growth of 125% is required to achieve expected profit on schedule.Breakeven Date Change • Mar 10Forecast breakeven date moved forward to 2023The 3 analysts covering SNDL previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 7.1% to 2022. The company is expected to make a profit of CA$11.0m in 2023. Average annual earnings growth of 81% is required to achieve expected profit on schedule.お知らせ • Feb 14SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022SNDL Inc. provided earnings guidance for the fourth quarter of 2022. The Company expects to report record net revenue and net cash provided by operating activities for the fourth quarter of 2022.お知らせ • Feb 08SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette on August 29, 2022. The consideration for the Stalking Horse Agreement is made up of (i) a credit bid and set-off of debt owing to SNDL through the assumption of certain assumed liabilities; and (ii) the cash payment of certain statutory priority payments and costs of terminating the CCAA proceeding and winding-down the relevant Superette entities. SNDL has agreed to provide up to an additional $2.1 million in pre-CCAA and debtor-in-possession financing for Superette for a total amount of $6.9 million. The comeback hearing is scheduled on September 9, 2022, Superette intends to seek approval of an amended and restated initial order and order approving a sale and investment solicitation process. The transaction is subject to Pre-Closing Reorganization Steps, approval of AGCO and other customary closing conditions. As of September 9, 2022, the transaction has been approved by the court. As of December 20, 2022, Ontario Superior Court of Justice approval the transaction. Jamey Gage of McCarthy Tétrault LLP is acting as legal counsel to SNDL. Joseph J. Bellissimo and Monique Sassi of Cassels, Brock & Blackwell LLP is acting as legal counsel to Superette. Michael McTaggart of PricewaterhouseCoopers Inc. is acting as a monitor of Superette with respect to the CCAA Proceedings and is represented by Sean H. Zweig and Mike Shakra of Bennett Jones LLP. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette on February 7, 2023.お知らせ • Jan 19+ 1 more updateSNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 94.2 million on August 22, 2022. Under the terms of the Agreement, Valens' shareholders will receive, for each Valens Share, 0.3334 of a common share of SNDL. The combined company will operate as SNDL Inc., and Valens shareholders will own approximately 9.5% of the pro forma entity. The Agreement provides for, among other things, customary support and non-solicitation covenants from Valens, including customary "fiduciary out" provisions that allow Valens to accept a superior proposal in certain circumstances and a five-business day "right to match period" in favour of SNDL. The Agreement also provides for the payment of a termination fee of CAD 8 million payable to SNDL by Valens in the event the Transaction is terminated in certain specified circumstances. The Transaction will be carried out by way of a court-approved plan of arrangement under the Canada Business Corporations Act. The implementation of the Transaction will be subject to the approval of at least two thirds of the Valens Shares entitled to be voted by Valens shareholders and the approval of a simple majority of the Valens Shares entitled to be voted by Valens shareholders, other than Valens shareholders required to be excluded under applicable laws, at a special meeting expected to be convened by Valens by the end of November 2022 (the "Meeting"), Shares to be issued pursuant to the Arrangement shall have been approved for listing on Nasdaq, and the receipt of applicable orders from the Ontario Superior Court of Justice and applicable regulatory approvals, including under the Competition Act (Canada) and the applicable provincial liquor and cannabis regulators. Valens' board of directors has unanimously approved the Transaction after receiving the unanimous recommendation of a special committee of Valens directors (the "Special Committee"). Valens' board of directors has unanimously resolved to recommend that the shareholders of Valens vote in favour of the Transaction. SNDL’s Board of Directors also unanimously approved the Transaction. All directors and executive officers of Valens have entered into voting support agreements with SNDL pursuant to which, among other things, the parties have agreed to vote their Valens Shares in favour of the Transaction. The shareholders meeting of Valens is scheduled on November 29, 2022. As of November 22, 2022, both Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) have recommended that Valens shareholders (the “Valens Shareholders”) vote in favour of the arrangement. On November 29, 2022, shareholders of Valens approved the transaction. As of December 13, 2022, The Valens Company has been granted additional 180 calendar day grace period by Nasdaq to regain compliance with Minimum Bid Price rule. As a result of the extension, The Valens Company now has until June 12, 2023, to regain compliance with the Bid Price Requirement. The Ontario Superior Court of Justice (Commercial List) has granted a final order approving the transaction. The transaction is expected to close during January 2023. Together with incremental revenues from greater distribution of Valens products, it is estimated that the Transaction will deliver upwards of CAD 15 million of additional EBITDA on an annual run-rate basis through synergies and other strategic initiatives. Cormark Securities Inc. has provided a fairness opinion to the Special Committee of Valens that, subject to the assumptions, limitations and qualifications set out in such fairness opinion, the consideration to be received by Valens shareholders pursuant to the Transaction is fair from a financial point of view to Valens' shareholders. ATB Capital Markets Inc. is acting as financial advisor to SNDL. Ranjeev Dhillon and Rami Chalabi of McCarthy Tétrault LLP acting as legal counsels to SNDL. Cormark Securities Inc. is acting as financial advisor and Donald Belovich of Stikeman Elliott LLP is acting as legal counsel to Valens. Laurel Hill Advisory Group, LLC acted as information agent with a service fee of $50,000 (CAD 67,869) and Computershare Investor Services Inc. acted transfer agent to Valens. Marcum LLP acted as accountant while Odyssey Trust Company acted as transfer agent to SNDL. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS) on January 17, 2023. Frank Krasovec has been appointed to the Board of Directors of SNDL, effective January 17, 2023. The Board now consists of six directors. Zach George will continue to serve as Chief Executive Officer of SNDL and Tyler Robson, the former CEO of Valens, will join the leadership team as President of Cannabis. Andrew Stordeur, SNDL's former President and Chief Operating Officer has left the company effective January 13, 2023. Immediately prior to the effective date of the Transaction, SNDL owned an aggregate of 6.5 million Valens Shares, representing approximately 8.1% of the outstanding Valens Shares at such time. Following the closing of the Transaction, there are 260.7 million SNDL Shares outstanding, with existing SNDL Shareholders holding approximately 89.4% of such outstanding SNDL Shares and former Valens Shareholders holding approximately 10.6% of such outstanding SNDL Shares. The Valens Shares are expected to be delisted from the Toronto Stock Exchange.お知らせ • Nov 17SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 11,800,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is to to opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2023.お知らせ • Oct 29SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022SNDL Inc. announced that they will report Q3, 2022 results on Nov 14, 2022お知らせ • Sep 01SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette on August 30, 2022. The consideration for the Stalking Horse Agreement is made up of (i) a credit bid and set-off of debt owing to SNDL through the assumption of certain assumed liabilities; and (ii) the cash payment of certain statutory priority payments and costs of terminating the CCAA proceeding and winding-down the relevant Superette entities. SNDL has agreed to provide up to an additional $2.1 million in pre-CCAA and debtor-in-possession financing for Superette for a total amount of $6.9 million. The comeback hearing is scheduled on September 9, 2022, Superette intends to seek approval of an amended and restated initial order and order approving a sale and investment solicitation process. McCarthy Tétrault LLP is acting as legal counsel to SNDL. Cassels, Brock & Blackwell LLP is acting as legal counsel to Superette. PricewaterhouseCoopers Inc. is acting as a monitor of Superette with respect to the CCAA Proceedings and is represented by Bennett Jones LLP.お知らせ • Aug 03SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022SNDL Inc. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 12, 2022お知らせ • Jul 26Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022Sundial Growers Inc. announced resignation of David Gordey as Chief Administrative Officer, effective July 29, 2022.お知らせ • Jul 07Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million on September 2, 2021. Consideration for the Rocky View Facility is comprised of CAD 1.5 million cash and a CAD 3.5 million mortgage in favour of Sundial. Simply Solventless Concentrates has launched a private placement of convertible debentures for proceeds of $1 million and the proceeds will be used for inventory, minor capital expenditures, the advancement of its branded product strategy and general working capital purposes. Simply Solventless Concentrates' Licence Agreement with Sundial Growers with regard to the facility will terminate upon closing of the transaction. It is anticipated that the transaction will close in late Q4 2021 or Q1 2022 upon receipt of SSC's Health Canada licences. Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL) on July 6, 2022.お知らせ • May 14Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022Sundial Growers Inc. announced that they will report Q1, 2022 results After-Market on May 16, 2022お知らせ • Apr 16Sundial Growers Inc., Annual General Meeting, Jun 27, 2022Sundial Growers Inc., Annual General Meeting, Jun 27, 2022.お知らせ • Mar 29Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022Sundial Growers Inc. announced that they will report Q4, 2021 results on Apr 14, 2022お知らせ • Feb 09Sundial Receives 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid RuleSundial Growers Inc. announced that it has received an extension of 180 calendar days to regain compliance with Nasdaq's minimum bid price requirement. As previously reported, the Company was notified by Nasdaq on August 9, 2021 that the bid price for its common shares was not in compliance with the Nasdaq minimum bid price requirement. At that time, the Company was required to regain compliance by February 7, 2022. The extension will allow the Company to regain compliance if the bid price for the Company's common shares closes at or above $1.00 per share for a minimum of 10 consecutive trading days before August 8, 2022.お知らせ • Sep 04Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million.Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million on September 2, 2021. Consideration for the Rocky View Facility is comprised of CAD 1.5 million cash and a CAD 3.5 million mortgage in favour of Sundial. Simply Solventless Concentrates' Licence Agreement with Sundial Growers with regard to the facility will terminate upon closing of the transaction. It is anticipated that the transaction will close in late Q4 2021 or Q1 2022 upon receipt of SSC's Health Canada licences.お知らせ • May 13An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL).An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL) on March 23, 2021. Sundial Growers Inc decreased from 50% to 25%, resulting in a loss of control. As a result of the loss of control, Sundial has de-recognized the assets and liabilities of Pathway, and the non-controlling interest arising upon the acquisition of Pathway. A loss on loss of control of $1.9 million was recognized during the three months ended March 31, 2021. An unknown byer completed the acquisition of 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL) on March 23, 2021.お知らせ • May 07Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million.Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million on May 5, 2021. Under the terms of the Agreement, Inner Spirit's shareholders will receive, for each Inner Spirit common share held, (i) $0.30 in cash and (ii) 0.0835 of a Sundial common share. The Agreement also provides for the payment of a reciprocal termination fee of $4 million in the event the Transaction is terminated in certain specified circumstances. The implementation of the Transaction will be subject to the approval of at least two thirds of the shares voted by Inner Spirit shareholders at a special meeting expected to be convened by Inner Spirit in July 2021, and the receipt of applicable orders from the Court of Queen's Bench of Alberta and applicable regulatory approvals. The Transaction has been unanimously approved by the Boards of Directors of Sundial and Inner Spirit and has resolved to recommend that Inner Spirit shareholders vote in favour of the Transaction. The transaction is expected to close early in the third quarter of 2021. Echelon Capital Markets, financial advisor to Inner Spirit, has provided a fairness opinion to the Board of Directors of Inner Spirit. ATB Capital Markets is acting as financial advisor to Sundial. McCarthy Tétrault LLP is acting as legal counsel to Sundial. Burstall LLP is acting as legal counsel to Inner Spirit.お知らせ • Mar 16Sundial and SAF Group Announce Strategic Capital PartnershipSundial Growers Inc. announced they have entered into an agreement to form a 50/50 joint venture through a new corporation, SunStream Bancorp Inc. The Joint Venture will leverage a strategic financial and operational partnership to generate asymmetrically enhanced risk-return opportunities in the cannabis industry to provide exposure to a portfolio of attractive debt, equity and hybrid investments. The Joint Venture will focus on cannabis-related verticals, seeking both Canadian and international opportunities and investments. The Joint Venture's first mandate is the formation of a special opportunities fund with commitments from third party limited partners alongside an initial commitment from Sundial of $100 million. The Joint Venture expects to pursue additional potential mandates, including a Canadian SPAC and other investments.お知らせ • Mar 03Sundial Growers Inc. to Report Q4, 2020 Results on Mar 17, 2021Sundial Growers Inc. announced that they will report Q4, 2020 results After-Market on Mar 17, 2021お知らせ • Feb 18Sundial Regains Compliance with Nasdaq Minimum Bid Price RuleSundial Growers Inc. announced that the Nasdaq Stock Market ("Nasdaq") has confirmed that the Company has regained compliance with Nasdaq's minimum bid price requirements for continued listing on the Nasdaq Capital Market. As a result of the closing bid price of the Sundial's common shares having been at $1.00 per share or greater for at least ten consecutive business days, the Company has regained compliance with Nasdaq's Listing Rule, and the matter is now closed.お知らせ • Feb 04Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million.Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million. Security Name: Series A Units Security Type: Equity/Derivative Unit Securities Offered: 100,000,000 Price\Range: $0.75 Security Name: Series B Units Security Type: Equity/Derivative Unit Securities Offered: 33,333,334 Price\Range: $0.7499 Transaction Features: Registered Direct Offeringお知らせ • Jan 12Sundial Growers Inc. Announces the Launch of Premium Concentrates Products Under Its Top Leaf BrandSundial Growers Inc. launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial's focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges. Sundial has launched a bubble hash product under its Top Leaf brand and will launch other products such as pressed hash and live rosin with capabilities to expand future product offerings through different Sundial brands in the coming quarters. Solventless concentrates from Top Leaf brands are available for purchase in B.C. and Alberta, with plans to be available across the country in the coming months. The Top Leaf brand currently offers Pink Kush and Bubba in the bubble hash format. All Top Leaf concentrate products are produced from high-quality, single-strain, fresh-frozen flower that is produced to preserve its terpene and cannabinoid profile. There are no additives, no fillers and no artificial flavors added to the products. Sundial plans on providing additional offerings in the first quarter of 2021 including Top Leaf's Oregon Golden Goat bubble hash and Grasslands' Sativa & Indica hash.お知らせ • Jan 01Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million.Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million on December 30, 2020. Pursuant to the terms of the Senior Loan, Zenabis will also pay Sundial a royalty based on quarterly sales revenue from its medical, recreational and wholesale cannabis lines net of value added or sales taxes which will be payable each fiscal quarter as follows 3.5% of Net Cannabis Revenue where Net Cannabis Revenue does not exceed CAD 25 million, 3.0% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 25 million but not CAD 30 million, 2.5% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 30 million but not CAD 37.5 million; and 2.0% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 37.5 million. Consideration was funded from Sundial's available cash reserves totaling $110 million prior to the acquisition's closing. Sundial Growers Inc. (NasdaqCM:SNDL) completed the acquisition of Senior Secured Loans of Zenabis Investments Ltd on December 30, 2020.お知らせ • Dec 29Sundial Announces Concentrates Licence Agreement with Simply SolventlessSundial Growers Inc. announced that it has entered into a licence agreement with Simply Solventless Concentrates Ltd. for the processing and manufacturing of a suite of solventless cannabis concentrates products by Sundial in its Rocky View facility using SSC's intellectual property. The Agreement will enable Sundial to utilize its Rocky View asset, while enhancing its focus on producing premium inhalables. The new agreement also provides the Company the opportunity to leverage SSC's knowledge and expertise regarding concentrates manufacturing with an expanded line of products. Under the Agreement, SSC will receive a royalty on the sale of products manufactured using the SSC brand and technology. SSC will supply the non-cannabis materials to produce SSC concentrate products, in addition to paying Sundial a monthly administration fee. A minimum of 75% of the cannabis materials required for the processing and manufacturing of SSC products will be cultivated by Sundial unless such inventory is unavailable. Sundial expects to scale the distribution of SSC products across the country, with the first SSC products targeted to be in stores in the second quarter of 2021. With SSC's support, Sundial will utilize its craft at scale approach to produce and package the cannabis concentrate products, while leveraging its established sales and distribution infrastructure to get the products to market with speed and scale.お知らせ • Dec 13Sundial Growers Transfers Listing to Extend Regaining Compliance PeriodOn December 11, 2020, Sundial Growers Inc. announced that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. The Company had sought the transfer to take advantage of the additional 180 calendar day compliance period offered on the Nasdaq Capital Market, which will extend the period that the Company has to regain compliance with Nasdaq's minimum bid price requirement. The transfer is expected to become effective on December 15, 2020. As previously reported, the Company was notified by Nasdaq on May 12, 2020 that the bid price for its common shares was not in compliance with the Nasdaq minimum bid price requirement. At that time, the Company had until December 28, 2020 to regain compliance. The anticipated extension will allow the Company to regain compliance if for a minimum of 10 consecutive business days before June 26, 2021 the bid price for the Company's common shares closes at or above $1.00 per share. The Company intends to monitor the closing bid price of its common shares and has given written assurance to Nasdaq that it will, if necessary, implement available options to regain compliance with the minimum bid price requirement, including a reverse stock split.Is New 90 Day High Low • Dec 01New 90-day high: €0.60The company is up 138% from its price of €0.25 on 02 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.Analyst Estimate Surprise Post Earnings • Nov 12Revenue misses expectationsRevenue missed analyst estimates by 43%. Over the next year, revenue is forecast to grow 36%, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany.Reported Earnings • Nov 12Third quarter 2020 earnings released: CA$0.53 loss per shareThe company reported a soft third quarter result with weaker revenues and control over expenses, though losses reduced. Third quarter 2020 results: Revenue: CA$12.9m (down 62% from 3Q 2019). Net loss: CA$71.4m (loss narrowed 27% from 3Q 2019).お知らせ • Nov 10Sundial Growers Inc. Enters into Sales and Distribution Agreement with Choklat IncSundial Growers Inc. announced that it has entered into a sales and distribution agreement with Choklat Inc. The new collaboration between the two Alberta-based companies provides Sundial the opportunity to continue to expand its product portfolio and enter the edible market. As part of the contractual arrangement, Sundial and Choklat will launch a cannabis-infused confectionary brand, offering a selection of chocolate bars, drinking chocolate and infused sugar, all containing 10 milligrams of THC, the highest amount legal to sell in a single edible serving in Canada. Both companies expect to scale the collaboration across the country with first product targeting to be in-stores ahead of the holiday season in Alberta. Under the terms of the Agreement, Choklat will produce and package the products and Sundial will use its sales and distribution infrastructure to get the product on retailers' shelves. This agreement will enable both companies to capitalize on what they do best, which is produce conventional chocolate products for Choklat and produce premium cannabis products for Sundial. Choklat has a proven track record of producing craft chocolate confections, using the best quality ingredients. Choklat products are currently available in 110 groceries stores across Alberta and is producing its cannabis-infused confections in its 6,000 square-foot facility located in Calgary, Alberta. Sundial will ensure rigorous testing protocols are in place to guarantee the high-quality products its consumers are used to, as well as using only cannabis products with no fillers, additives or artificial flavouring.お知らせ • Oct 30Sundial Growers Inc. to Report Q3, 2020 Results on Nov 11, 2020Sundial Growers Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 11, 2020お知らせ • Oct 06+ 1 more updateDavid Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million.David Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million on May 15, 2020. As consideration for the Bridge Farm Disposition, buyer will (i) assume CAD 45 million of debt under Sundial's existing CAD 115 million term debt facility, (ii) assume the contingent consideration liabilities related to the remaining earn-out and additional share obligations under the original Bridge Farm acquisition agreement, dated as of July 2, 2019, and (iii) cancel approximately 2.7 million of Sundial common shares currently held by certain members of buyer. Sundial will not receive any cash consideration in connection with the transaction. The consideration is subject to some adjustment. The transaction was backed by Artemis Growth Partners. Following completion of the deal David Ball, a partner at Artemis Growth Partners, will re-join Bridge Farm as director of and advisor to the business. The Bridge Farm Disposition is subject to standard closing conditions and is further conditioned on Sundial restructuring the remaining CAD 70 million under its Term Debt Facility and entering into a new syndicated credit agreement with the Company's senior lenders on or before June 1, 2020. Upon termination buyer will pay CAD 1 million to seller as a termination fee. Closing is subject to the following conditions-a) each of the Fundamental Warranties given in favour of the Buyer pursuant to this Agreement; and the Warranties under Schedule 2, if so given in favour of the Buyer on the Closing Date, should be true and correct in all respects on the Closing Date and the Seller shall have executed and delivered to the Buyer a certificate confirming that the Fundamental Warranties in this Agreement and the Warranties under paragraph 30 of Part 2 of Schedule 2 are given on that basis b) the Seller should have performed, fulfilled and complied, and shall have caused the Group Entities to perform, fulfill and comply, with all of the obligations, covenants and conditions of this Agreement to be performed c) the Seller shall deliver to the Buyer within 5 Business Days before Closing its balance sheet evidencing its solvency d) no written notice having been received by the Parties of any legal or regulatory action, which would lead to termination of the transaction and there should be no injunction in effect against Closing entered by a court of competent jurisdiction against buyer and seller. e) David Ball and the management team should have secured unconditional funding of CAD 45 million from SAF and agreed the terms of the SAF Facility Deeds of Novation with SAF and the Seller and received consent from the Seller’s Guarantors Banks in respect of the matters contemplated in this Agreement. f) the Buyer shall have received written consent in a form reasonably satisfactory to SAF. g) Buyer Warranties made in favour of the Seller pursuant to this Agreement shall have been true and correct in all material respects on the date of this agreement and the Buyer have performed, fulfilled and complied with all of the obligations, covenants and conditions of this Agreement to be performed. h) the Seller shall have agreed the terms of the SAF Facility Deeds of Novation with SAF and the Buyer. Clearwater International acted as financial advisor, KPMG acted as accountant, with Pierce Atwood and Gavin Cummings and Shaun McCabe of Browne Jacobson acted as legal advisor to the buyers in the transaction. Robert Brant of Mccarthy Tetrault acted as legal advisor for Sundial Growers. Davies Ward Phillips & Vineberg acted as legal advisor for Artemis Growth Partners.お知らせ • Aug 21Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million.Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million. Security Name: Series A Units Security Type: Equity/Derivative Unit Securities Offered: 25,820,000 Price\Range: $0.5 Discount Per Security: $0.03 Security Name: Series B Units Security Type: Equity/Derivative Unit Securities Offered: 14,280,000 Price\Range: $0.4999 Discount Per Security: $0.029994 Transaction Features: Registered Direct Offeringお知らせ • Aug 18Sundial Growers Inc. announced that it has received $18 million in fundingOn June 8, 2020, Sundial Growers Inc. (NasdaqGS:SNDL) closed the transaction. The transaction included participation from institutional investors. The conversion price of the notes is subject to adjustment in the event the company sells shares of common stock or common stock equivalents for less than $1 per share in the future, subject to customary excluded issuances. The company also issued warrants to purchase 14,457,059 shares at an exercise price of $0.9338 per warrant. The warrants will expire 3.5 years from the date that the underlying shares become freely tradable.お知らせ • Jul 31Sundial Growers Inc. to Report Q2, 2020 Results on Aug 13, 2020Sundial Growers Inc. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 13, 2020株主還元VY4DE PharmaceuticalsDE 市場7D2.5%3.4%0.6%1Y6.1%26.6%0.2%株主還元を見る業界別リターン: VY4過去 1 年間で26.6 % の収益を上げたGerman Pharmaceuticals業界を下回りました。リターン対市場: VY4過去 1 年間で0.2 % の収益を上げたGerman市場を上回りました。価格変動Is VY4's price volatile compared to industry and market?VY4 volatilityVY4 Average Weekly Movement8.2%Pharmaceuticals Industry Average Movement6.3%Market Average Movement6.1%10% most volatile stocks in DE Market13.2%10% least volatile stocks in DE Market2.7%安定した株価: VY4 、 German市場と比較して、過去 3 か月間で大きな価格変動はありませんでした。時間の経過による変動: VY4の 週次ボラティリティ ( 8% ) は過去 1 年間安定しています。会社概要設立従業員CEO（最高経営責任者ウェブサイト20062,751Zach Georgewww.sndl.comSNDL Inc.はカナダで大麻製品の生産、流通、販売に従事している。同社は4つのセグメントを通じて事業を展開している：酒類小売、大麻小売、大麻事業、投資。成人用・医療用大麻の栽培・流通・販売、ワイン・アンド・ビヨンド、エース・リカー、リカー・デポの各酒販店を通じてのワイン・ビール・蒸留酒の販売、自社およびフランチャイズの大麻小売店を通じての成人用大麻製品・付属品の個人販売などを行っている。また、フラワー、プレロール、VAPEの製造・販売、金融サービスも提供している。Top Leaf、Contraband、Palmetto、Bon Jak、La Logue、Versus、Grasslands、Pearls by Grön、No Future、Bhang Chocolateのブランドで製品を提供している。同社は以前Sundial Growers Inc.として知られていたが、2022年7月にSNDL Inc.に社名を変更した。SNDL社は2006年に法人化され、カナダのカルガリーに本社を置いている。もっと見るSNDL Inc. 基礎のまとめSNDL の収益と売上を時価総額と比較するとどうか。VY4 基礎統計学時価総額€322.66m収益（TTM）-€6.86m売上高(TTM)€585.59m0.6xP/Sレシオ-48.0xPER（株価収益率VY4 は割高か？公正価値と評価分析を参照収益と収入最新の決算報告書（TTM）に基づく主な収益性統計VY4 損益計算書（TTM）収益CA$937.39m売上原価CA$682.57m売上総利益CA$254.82mその他の費用CA$265.80m収益-CA$10.98m直近の収益報告Mar 31, 2026次回決算日該当なし一株当たり利益（EPS）-0.042グロス・マージン27.18%純利益率-1.17%有利子負債／自己資本比率0%VY4 の長期的なパフォーマンスは？過去の実績と比較を見るView Valuation企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/21 19:19終値2026/05/21 00:00収益2026/03/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋SNDL Inc. 2 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。9 アナリスト機関Aaron GreyAlliance Global PartnersFrederico Yokota Choucair GomesATB CormarkDavid KideckelATB Cormark6 その他のアナリストを表示
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director James Cannell was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 16SNDL Inc. to Report Q1, 2026 Results on Apr 29, 2026SNDL Inc. announced that they will report Q1, 2026 results Pre-Market on Apr 29, 2026
お知らせ • Mar 31SNDL Inc. Announces Executive Changes for Cannabis SegmentSNDL Inc. announced on March 30, 2026 that Tyler Robson, President of Cannabis, has left the Company in order to pursue other opportunities. Ryan Hellard, SNDL’s current Chief Strategy Officer, will assume the role of Interim President of Cannabis. The Company wishes Mr. Robson success in his future endeavours.
お知らせ • Feb 20SNDL Inc. to Report Q4, 2025 Results on Mar 12, 2026SNDL Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026
お知らせ • Nov 22SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 24,500,000 shares, for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 24,500,000 common shares, representing 10% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2026.
お知らせ • Oct 16SNDL Inc. to Report Q3, 2025 Results on Nov 04, 2025SNDL Inc. announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 04, 2025
Board Change • May 20Insufficient new directorsThere is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. No highly experienced directors. Independent Director James Cannell was the last director to join the board, commencing their role in 2024. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model.
お知らせ • Apr 16SNDL Inc. to Report Q1, 2026 Results on Apr 29, 2026SNDL Inc. announced that they will report Q1, 2026 results Pre-Market on Apr 29, 2026
お知らせ • Mar 31SNDL Inc. Announces Executive Changes for Cannabis SegmentSNDL Inc. announced on March 30, 2026 that Tyler Robson, President of Cannabis, has left the Company in order to pursue other opportunities. Ryan Hellard, SNDL’s current Chief Strategy Officer, will assume the role of Interim President of Cannabis. The Company wishes Mr. Robson success in his future endeavours.
お知らせ • Feb 20SNDL Inc. to Report Q4, 2025 Results on Mar 12, 2026SNDL Inc. announced that they will report Q4, 2025 results Pre-Market on Mar 12, 2026
お知らせ • Nov 22SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 24,500,000 shares, for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 24,500,000 common shares, representing 10% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2026.
お知らせ • Oct 16SNDL Inc. to Report Q3, 2025 Results on Nov 04, 2025SNDL Inc. announced that they will report Q3, 2025 results at 9:30 AM, US Eastern Standard Time on Nov 04, 2025
お知らせ • Jul 11SNDL Inc. to Report Q2, 2025 Results on Jul 31, 2025SNDL Inc. announced that they will report Q2, 2025 results Pre-Market on Jul 31, 2025
お知らせ • Jun 23SNDL Inc., Annual General Meeting, Jul 29, 2025SNDL Inc., Annual General Meeting, Jul 29, 2025.
お知らせ • Apr 15SNDL Inc. to Report Q1, 2025 Results on May 01, 2025SNDL Inc. announced that they will report Q1, 2025 results Pre-Market on May 01, 2025
お知らせ • Feb 26SNDL Inc. to Report Q4, 2024 Results on Mar 18, 2025SNDL Inc. announced that they will report Q4, 2024 results at 9:30 AM, US Eastern Standard Time on Mar 18, 2025
お知らせ • Nov 22SNDL Inc. Announces Executive AppointmentsSNDL Inc. announced the appointments of Phil McBride as Chief Information Officer and Navroop Sandhawalia as President, Liquor Division. Phil McBride joins SNDL with more than 25 years of experience across consumer-packaged goods, financial services and retail industries, having held leadership roles at OMERS, Molson Coors, Aeroplan, and Proctor & Gamble. His demonstrated capabilities include digital transformation, data analytics advancement, the integration of generative AI technologies, and stewardship of one of Canada's most successful loyalty programs. Navroop Sandhawalia, who joined SNDL in October 2023 as Vice President of Finance, and was promoted to Interim President, Liquor Division in September, has made significant contributions to performance management and operational efficiency, driving improved decision-making across the liquor business. His experience includes over 13 years at Loblaws where he held various roles within finance, analytics and data science.
お知らせ • Nov 15SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,200,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 13,200,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2025.
お知らせ • Nov 06SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H).SNDL Inc. (NasdaqCM:SNDL) enters into a stalking horse purchase agreement to acquire a remaining majority stake in Indiva Limited (TSXV:NDVA.H) for CAD 22.7 million on July 5, 2024. PricewaterhouseCoopers Inc. (The Monitor) currently estimates the value of the credit bid and cash consideration payable by SNDL under the Bid Agreement to be in the range of approximately CAD 25 million to CAD 28 million. As of July 8, 2024, the Court has approved the sale process. The Transaction is anticipated to close during SNDL's fourth quarter following the receipt of all such approvals. Indiva will seek approval for the Transaction from the Court on or about September 19, 2024. As per filing on August 29, 2024, stalking horse bid of SNDL has been chosen as the successful bid in the acquisition of Indiva. McCarthy Tétrault LLP is acting as legal counsel for SNDL, Bennett Jones LLP is acting as legal counsel for the Indiva Group, and Osler Hoskin & Harcourt LLP is acting as legal counsel for PricewaterhouseCoopers Inc. (the monitor). SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining majority stake in Indiva Limited (TSXV:NDVA.H) on November 4, 2024.
お知らせ • Oct 25SNDL Inc. to Report Q3, 2024 Results on Nov 05, 2024SNDL Inc. announced that they will report Q3, 2024 results Pre-Market on Nov 05, 2024
お知らせ • Oct 22SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC).SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.4 million on August 12, 2024. Under the terms of the Agreement, Nova's shareholders will receive CAD 1.75 in cash for each Nova Share. Nova shareholders also have the ability to elect to receive, in lieu of the Cash Consideration, 0.58 of a common share of SNDL for each Nova Share, subject to proration and a maximum of 50% of the aggregate Consideration being payable in SNDL Shares. The Agreement also provides for the payment of a termination fee of CAD 800,000 payable to SNDL by Nova in the event the Transaction is terminated in certain specified circumstances. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada. The transaction is subject to Key Regulatory Approvals. The Transaction has been approved by the boards of directors of both SNDL and Nova. As of October 16, 2024, The Transaction has been approved by Nova shareholders. The Transaction is expected to close on or before October 18, 2024. Ranjeev Dhillon and Rami Chalabi of McCarthy Tétrault LLP is acting as legal counsel to SNDL. Eight Capital is acting as financial advisor and Jon Truswel of Bennett Jones LLP is acting as legal counsel to Nova. Eight Capital Inc. acted as fairness opinion provider to Nova. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) on October 21, 2024. In connection with the Arrangement, SNDL intends to appoint to its board of directors J. Carlo Cannell. The Court of King's Bench of Alberta granted a final order approving the Arrangement on October 17, 2024. The Nova Shares are expected to be delisted from the TSX and the OTC Markets. Following the delisting of the Nova Shares, Nova intends to submit an application to cease to be a reporting issuer in each applicable jurisdiction of Canada pursuant to applicable securities laws, and, following which, SNDL intends to amalgamate with Nova pursuant to the provisions of the Business Corporations Act (Alberta). Odyssey Trust Company acted as depository to Nova Cannabis.
お知らせ • Oct 21SNDL Inc. Appoints J. Carlo to Its Board of DirectorsSNDL Inc. announced that in connection with the Arrangement, SNDL intends to appoint to its board of directors J. Carlo, 61, a leading practitioner of special situations since the formation of Cannell Capital in 1992.
Breakeven Date Change • Oct 16No longer forecast to breakevenThe 2 analysts covering SNDL no longer expect the company to break even during the foreseeable future. The company was expected to make a profit of CA$3.90m in 2025. New consensus forecast suggests the company will make a loss of CA$14.5m in 2025.
お知らせ • Aug 14SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million.SNDL Inc. (NasdaqCM:SNDL) agreed to acquire 34.80% stake in Nova Cannabis Inc. (TSX:NOVC) for CAD 72.39 million on August 13, 2024. Under the terms of the Agreement, Nova's shareholders will receive CAD 1.75 in cash for each Nova Share. Nova shareholders also have the ability to elect to receive, in lieu of the Cash Consideration, 0.58 of a common share of SNDL for each Nova Share, subject to proration and a maximum of 50% of the aggregate Consideration being payable in SNDL Shares. The Agreement also provides for the payment of a termination fee of CAD 800,000 payable to SNDL by Nova in the event the Transaction is terminated in certain specified circumstances. Following the closing of the Transaction, the Nova Shares are expected to be delisted from the TSX and Nova will apply to cease to be a reporting issuer in all provinces and territories of Canada. The Transaction has been approved by the boards of directors of both SNDL and Nova. The Transaction is expected to close on or before October 18, 2024. McCarthy Tétrault LLP is acting as legal counsel to SNDL. Eight Capital is acting as financial advisor and Bennett Jones LLP is acting as legal counsel to Nova. Eight Capital Inc. acted as fairness opinion provider to Nova.
お知らせ • Jul 20SNDL Inc. to Report Q2, 2024 Results on Aug 02, 2024SNDL Inc. announced that they will report Q2, 2024 results Pre-Market on Aug 02, 2024
お知らせ • Jun 24SNDL Inc., Annual General Meeting, Jul 30, 2024SNDL Inc., Annual General Meeting, Jul 30, 2024.
New Risk • May 10New major risk - Revenue and earnings growthEarnings have declined by 11% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (12% average weekly change). Earnings have declined by 11% per year over the past 5 years.
お知らせ • May 10SNDL Inc. Reports Asset Impairment Charges for the First Quarter Ended March 31, 2024SNDL Inc. reported asset impairment charges for the first quarter ended March 31, 2024. For the quarter, the company reported asset impairment of $1,656,000 against $807,000 a year ago.
Reported Earnings • May 09First quarter 2024 earnings released: CA$0.01 loss per share (vs CA$0.13 loss in 1Q 2023)First quarter 2024 results: CA$0.01 loss per share (improved from CA$0.13 loss in 1Q 2023). Revenue: CA$197.8m (down 2.3% from 1Q 2023). Net loss: CA$2.55m (loss narrowed 93% from 1Q 2023). Revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany. Over the last 3 years on average, earnings per share has increased by 61% per year but the company’s share price has fallen by 25% per year, which means it is significantly lagging earnings.
お知らせ • Apr 28SNDL Inc. to Report Q1, 2024 Results on May 09, 2024SNDL Inc. announced that they will report Q1, 2024 results Pre-Market on May 09, 2024
Reported Earnings • Mar 22Full year 2023 earnings released: CA$0.67 loss per share (vs CA$1.46 loss in FY 2022)Full year 2023 results: CA$0.67 loss per share (improved from CA$1.46 loss in FY 2022). Revenue: CA$909.0m (up 28% from FY 2022). Net loss: CA$168.1m (loss narrowed 50% from FY 2022). Revenue is forecast to grow 9.8% p.a. on average during the next 3 years, compared to a 3.4% growth forecast for the Pharmaceuticals industry in Germany. Over the last 3 years on average, earnings per share has increased by 81% per year but the company’s share price has fallen by 48% per year, which means it is significantly lagging earnings.
お知らせ • Mar 02SNDL Inc. to Report Fiscal Year 2023 Results on Mar 21, 2024SNDL Inc. announced that they will report fiscal year 2023 results Pre-Market on Mar 21, 2024
Reported Earnings • Nov 14Third quarter 2023 earnings released: CA$0.08 loss per share (vs CA$0.41 loss in 3Q 2022)Third quarter 2023 results: CA$0.08 loss per share (improved from CA$0.41 loss in 3Q 2022). Revenue: CA$237.6m (up 3.1% from 3Q 2022). Net loss: CA$21.8m (loss narrowed 78% from 3Q 2022). Over the last 3 years on average, earnings per share has increased by 98% per year but the company’s share price has fallen by 15% per year, which means it is significantly lagging earnings.
お知らせ • Nov 14SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 13,100,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 13,100,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2024.
お知らせ • Oct 28SNDL Inc. to Report Q3, 2023 Results on Nov 13, 2023SNDL Inc. announced that they will report Q3, 2023 results Pre-Market on Nov 13, 2023
お知らせ • Sep 16SNDL Inc. Launches New E-Commerce Platform for its Destination Liquor Retail banner, Wine and BeyondSNDL Inc. launched a new e-commerce platform for its destination liquor retail banner, Wine and Beyond. The platform aims to enhance accessibility and reach for the banner's expansive product selection, featuring rare spirits, local and international beers, and distinctive wines. Wine and Beyond's online catalogue features nearly 9,000 offerings, with fresh additions and new deals added weekly, backed by the banner's "Best Price Promise". Customers can further tailor their selections through product tasting notes and expertly curated food pairings and expand their knowledge through informed and seasonally relevant blog posts. The Company has 11 Wine and Beyond locations in Alberta and one in British Columbia, with plans to expand into Saskatchewan by 2024.
Reported Earnings • Aug 15Second quarter 2023 earnings released: CA$0.12 loss per share (vs CA$0.31 loss in 2Q 2022)Second quarter 2023 results: CA$0.12 loss per share (improved from CA$0.31 loss in 2Q 2022). Revenue: CA$244.5m (up 9.3% from 2Q 2022). Net loss: CA$29.4m (loss narrowed 60% from 2Q 2022). Over the last 3 years on average, earnings per share has increased by 104% per year but the company’s share price has fallen by 27% per year, which means it is significantly lagging earnings.
お知らせ • Aug 04SNDL Inc. to Report Q2, 2023 Results on Aug 14, 2023SNDL Inc. announced that they will report Q2, 2023 results Pre-Market on Aug 14, 2023
New Risk • Jul 20New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of German stocks, typically moving 9.8% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.8% average weekly change). Earnings have declined by 25% per year over the past 5 years. Minor Risk Shareholders have been diluted in the past year (9.3% increase in shares outstanding).
お知らせ • Jun 07SNDL Inc. Announces Chief Financial Officer ChangesSNDL Inc. announced the appointment of seasoned financial executive Alberto Paredero-Quiros as its new Chief Financial Officer. Mr. Paredero-Quiros brings more than 25 years of management experience in the consumer goods and pharmaceutical industries, with demonstrated leadership and financial expertise in world-class global organizations. He has held senior management roles for companies such as MondelezInternational Inc., Novartis, Newell Brands Inc., and Procter & Gamble Company, bringing extensive experience in public company reporting, mergers and acquisitions, internal controls and general financial and operational management. Mr. Paredero-Quiros' appointment will take effect on July 1, 2023. The company announced the retirement of Jim Keough for his pivotal role in building and shaping the Company for the past five years.
お知らせ • May 19SNDL Inc., Annual General Meeting, Jul 27, 2023SNDL Inc., Annual General Meeting, Jul 27, 2023.
お知らせ • May 10SNDL Inc. to Report Q1, 2023 Results on May 15, 2023SNDL Inc. announced that they will report Q1, 2023 results Pre-Market on May 15, 2023
Breakeven Date Change • Apr 26Forecast breakeven date moved forward to 2023The analyst covering SNDL previously expected the company to break even in 2024. New forecast suggests the company will make a profit of CA$11.0m in 2023. Earnings growth of 125% is required to achieve expected profit on schedule.
Breakeven Date Change • Apr 25Forecast breakeven date moved forward to 2023The 2 analysts covering SNDL previously expected the company to break even in 2024. New consensus forecast suggests the company will make a profit of CA$11.0m in 2023. Earnings growth of 125% is required to achieve expected profit on schedule.
Breakeven Date Change • Mar 10Forecast breakeven date moved forward to 2023The 3 analysts covering SNDL previously expected the company to break even in 2024. New consensus forecast suggests losses will reduce by 7.1% to 2022. The company is expected to make a profit of CA$11.0m in 2023. Average annual earnings growth of 81% is required to achieve expected profit on schedule.
お知らせ • Feb 14SNDL Inc. Provides Earnings Guidance for the Fourth Quarter of 2022SNDL Inc. provided earnings guidance for the fourth quarter of 2022. The Company expects to report record net revenue and net cash provided by operating activities for the fourth quarter of 2022.
お知らせ • Feb 08SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette.SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette on August 29, 2022. The consideration for the Stalking Horse Agreement is made up of (i) a credit bid and set-off of debt owing to SNDL through the assumption of certain assumed liabilities; and (ii) the cash payment of certain statutory priority payments and costs of terminating the CCAA proceeding and winding-down the relevant Superette entities. SNDL has agreed to provide up to an additional $2.1 million in pre-CCAA and debtor-in-possession financing for Superette for a total amount of $6.9 million. The comeback hearing is scheduled on September 9, 2022, Superette intends to seek approval of an amended and restated initial order and order approving a sale and investment solicitation process. The transaction is subject to Pre-Closing Reorganization Steps, approval of AGCO and other customary closing conditions. As of September 9, 2022, the transaction has been approved by the court. As of December 20, 2022, Ontario Superior Court of Justice approval the transaction. Jamey Gage of McCarthy Tétrault LLP is acting as legal counsel to SNDL. Joseph J. Bellissimo and Monique Sassi of Cassels, Brock & Blackwell LLP is acting as legal counsel to Superette. Michael McTaggart of PricewaterhouseCoopers Inc. is acting as a monitor of Superette with respect to the CCAA Proceedings and is represented by Sean H. Zweig and Mike Shakra of Bennett Jones LLP. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of Substantially all of the business and assets of Superette on February 7, 2023.
お知らせ • Jan 19+ 1 more updateSNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS).SNDL Inc. (NasdaqCM:SNDL) entered into an arrangement agreement to acquire remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS) for CAD 94.2 million on August 22, 2022. Under the terms of the Agreement, Valens' shareholders will receive, for each Valens Share, 0.3334 of a common share of SNDL. The combined company will operate as SNDL Inc., and Valens shareholders will own approximately 9.5% of the pro forma entity. The Agreement provides for, among other things, customary support and non-solicitation covenants from Valens, including customary "fiduciary out" provisions that allow Valens to accept a superior proposal in certain circumstances and a five-business day "right to match period" in favour of SNDL. The Agreement also provides for the payment of a termination fee of CAD 8 million payable to SNDL by Valens in the event the Transaction is terminated in certain specified circumstances. The Transaction will be carried out by way of a court-approved plan of arrangement under the Canada Business Corporations Act. The implementation of the Transaction will be subject to the approval of at least two thirds of the Valens Shares entitled to be voted by Valens shareholders and the approval of a simple majority of the Valens Shares entitled to be voted by Valens shareholders, other than Valens shareholders required to be excluded under applicable laws, at a special meeting expected to be convened by Valens by the end of November 2022 (the "Meeting"), Shares to be issued pursuant to the Arrangement shall have been approved for listing on Nasdaq, and the receipt of applicable orders from the Ontario Superior Court of Justice and applicable regulatory approvals, including under the Competition Act (Canada) and the applicable provincial liquor and cannabis regulators. Valens' board of directors has unanimously approved the Transaction after receiving the unanimous recommendation of a special committee of Valens directors (the "Special Committee"). Valens' board of directors has unanimously resolved to recommend that the shareholders of Valens vote in favour of the Transaction. SNDL’s Board of Directors also unanimously approved the Transaction. All directors and executive officers of Valens have entered into voting support agreements with SNDL pursuant to which, among other things, the parties have agreed to vote their Valens Shares in favour of the Transaction. The shareholders meeting of Valens is scheduled on November 29, 2022. As of November 22, 2022, both Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”) have recommended that Valens shareholders (the “Valens Shareholders”) vote in favour of the arrangement. On November 29, 2022, shareholders of Valens approved the transaction. As of December 13, 2022, The Valens Company has been granted additional 180 calendar day grace period by Nasdaq to regain compliance with Minimum Bid Price rule. As a result of the extension, The Valens Company now has until June 12, 2023, to regain compliance with the Bid Price Requirement. The Ontario Superior Court of Justice (Commercial List) has granted a final order approving the transaction. The transaction is expected to close during January 2023. Together with incremental revenues from greater distribution of Valens products, it is estimated that the Transaction will deliver upwards of CAD 15 million of additional EBITDA on an annual run-rate basis through synergies and other strategic initiatives. Cormark Securities Inc. has provided a fairness opinion to the Special Committee of Valens that, subject to the assumptions, limitations and qualifications set out in such fairness opinion, the consideration to be received by Valens shareholders pursuant to the Transaction is fair from a financial point of view to Valens' shareholders. ATB Capital Markets Inc. is acting as financial advisor to SNDL. Ranjeev Dhillon and Rami Chalabi of McCarthy Tétrault LLP acting as legal counsels to SNDL. Cormark Securities Inc. is acting as financial advisor and Donald Belovich of Stikeman Elliott LLP is acting as legal counsel to Valens. Laurel Hill Advisory Group, LLC acted as information agent with a service fee of $50,000 (CAD 67,869) and Computershare Investor Services Inc. acted transfer agent to Valens. Marcum LLP acted as accountant while Odyssey Trust Company acted as transfer agent to SNDL. SNDL Inc. (NasdaqCM:SNDL) completed the acquisition of remaining 91.9% stake in The Valens Company Inc. (TSX:VLNS) on January 17, 2023. Frank Krasovec has been appointed to the Board of Directors of SNDL, effective January 17, 2023. The Board now consists of six directors. Zach George will continue to serve as Chief Executive Officer of SNDL and Tyler Robson, the former CEO of Valens, will join the leadership team as President of Cannabis. Andrew Stordeur, SNDL's former President and Chief Operating Officer has left the company effective January 13, 2023. Immediately prior to the effective date of the Transaction, SNDL owned an aggregate of 6.5 million Valens Shares, representing approximately 8.1% of the outstanding Valens Shares at such time. Following the closing of the Transaction, there are 260.7 million SNDL Shares outstanding, with existing SNDL Shareholders holding approximately 89.4% of such outstanding SNDL Shares and former Valens Shareholders holding approximately 10.6% of such outstanding SNDL Shares. The Valens Shares are expected to be delisted from the Toronto Stock Exchange.
お知らせ • Nov 17SNDL Inc. (NasdaqCM:SNDL) announces an Equity Buyback for 11,800,000 shares, representing 5% for CAD 100 million.SNDL Inc. (NasdaqCM:SNDL) announces a share repurchase program. Under the program, the company will repurchase up to 11,800,000 common shares, representing 5% of its issued share capital for CAD 100 million. The purpose of the program is to to opportunistically return value to shareholders. All shares purchased pursuant to the Share Repurchase Program will be returned to treasury for cancellation. The program is valid till November 20, 2023.
お知らせ • Oct 29SNDL Inc. to Report Q3, 2022 Results on Nov 14, 2022SNDL Inc. announced that they will report Q3, 2022 results on Nov 14, 2022
お知らせ • Sep 01SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette.SNDL Inc. (NasdaqCM:SNDL) entered into a Stalking Horse Agreement to acquire Substantially all of the business and assets of Superette on August 30, 2022. The consideration for the Stalking Horse Agreement is made up of (i) a credit bid and set-off of debt owing to SNDL through the assumption of certain assumed liabilities; and (ii) the cash payment of certain statutory priority payments and costs of terminating the CCAA proceeding and winding-down the relevant Superette entities. SNDL has agreed to provide up to an additional $2.1 million in pre-CCAA and debtor-in-possession financing for Superette for a total amount of $6.9 million. The comeback hearing is scheduled on September 9, 2022, Superette intends to seek approval of an amended and restated initial order and order approving a sale and investment solicitation process. McCarthy Tétrault LLP is acting as legal counsel to SNDL. Cassels, Brock & Blackwell LLP is acting as legal counsel to Superette. PricewaterhouseCoopers Inc. is acting as a monitor of Superette with respect to the CCAA Proceedings and is represented by Bennett Jones LLP.
お知らせ • Aug 03SNDL Inc. to Report Q2, 2022 Results on Aug 12, 2022SNDL Inc. announced that they will report Q2, 2022 results at 4:00 PM, US Eastern Standard Time on Aug 12, 2022
お知らせ • Jul 26Sundial Growers Inc. Announces Resignation of David Gordey as Chief Administrative Officer, Effective July 29, 2022Sundial Growers Inc. announced resignation of David Gordey as Chief Administrative Officer, effective July 29, 2022.
お知らせ • Jul 07Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL).Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million on September 2, 2021. Consideration for the Rocky View Facility is comprised of CAD 1.5 million cash and a CAD 3.5 million mortgage in favour of Sundial. Simply Solventless Concentrates has launched a private placement of convertible debentures for proceeds of $1 million and the proceeds will be used for inventory, minor capital expenditures, the advancement of its branded product strategy and general working capital purposes. Simply Solventless Concentrates' Licence Agreement with Sundial Growers with regard to the facility will terminate upon closing of the transaction. It is anticipated that the transaction will close in late Q4 2021 or Q1 2022 upon receipt of SSC's Health Canada licences. Simply Solventless Concentrates Ltd. completed the acquisition of Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc.. from Sundial Growers Inc. (NasdaqCM:SNDL) on July 6, 2022.
お知らせ • May 14Sundial Growers Inc. to Report Q1, 2022 Results on May 16, 2022Sundial Growers Inc. announced that they will report Q1, 2022 results After-Market on May 16, 2022
お知らせ • Apr 16Sundial Growers Inc., Annual General Meeting, Jun 27, 2022Sundial Growers Inc., Annual General Meeting, Jun 27, 2022.
お知らせ • Mar 29Sundial Growers Inc. to Report Q4, 2021 Results on Apr 14, 2022Sundial Growers Inc. announced that they will report Q4, 2021 results on Apr 14, 2022
お知らせ • Feb 09Sundial Receives 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid RuleSundial Growers Inc. announced that it has received an extension of 180 calendar days to regain compliance with Nasdaq's minimum bid price requirement. As previously reported, the Company was notified by Nasdaq on August 9, 2021 that the bid price for its common shares was not in compliance with the Nasdaq minimum bid price requirement. At that time, the Company was required to regain compliance by February 7, 2022. The extension will allow the Company to regain compliance if the bid price for the Company's common shares closes at or above $1.00 per share for a minimum of 10 consecutive trading days before August 8, 2022.
お知らせ • Sep 04Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million.Simply Solventless Concentrates Ltd. entered into an asset purchase agreement to acquire Fully Licenced Cultivation and Processing Facility of Sundial Growers Inc. from Sundial Growers Inc. (NasdaqCM:SNDL) for CAD 5 million on September 2, 2021. Consideration for the Rocky View Facility is comprised of CAD 1.5 million cash and a CAD 3.5 million mortgage in favour of Sundial. Simply Solventless Concentrates' Licence Agreement with Sundial Growers with regard to the facility will terminate upon closing of the transaction. It is anticipated that the transaction will close in late Q4 2021 or Q1 2022 upon receipt of SSC's Health Canada licences.
お知らせ • May 13An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL).An unknown byer acquired 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL) on March 23, 2021. Sundial Growers Inc decreased from 50% to 25%, resulting in a loss of control. As a result of the loss of control, Sundial has de-recognized the assets and liabilities of Pathway, and the non-controlling interest arising upon the acquisition of Pathway. A loss on loss of control of $1.9 million was recognized during the three months ended March 31, 2021. An unknown byer completed the acquisition of 25% stake in Pathway RX Inc from Sundial Growers Inc. (NasdaqCM:SNDL) on March 23, 2021.
お知らせ • May 07Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million.Sundial Growers Inc. (NasdaqCM:SNDL) entered into an agreement to acquire Inner Spirit Holdings Ltd. (CNSX:ISH) for approximately CAD 120 million on May 5, 2021. Under the terms of the Agreement, Inner Spirit's shareholders will receive, for each Inner Spirit common share held, (i) $0.30 in cash and (ii) 0.0835 of a Sundial common share. The Agreement also provides for the payment of a reciprocal termination fee of $4 million in the event the Transaction is terminated in certain specified circumstances. The implementation of the Transaction will be subject to the approval of at least two thirds of the shares voted by Inner Spirit shareholders at a special meeting expected to be convened by Inner Spirit in July 2021, and the receipt of applicable orders from the Court of Queen's Bench of Alberta and applicable regulatory approvals. The Transaction has been unanimously approved by the Boards of Directors of Sundial and Inner Spirit and has resolved to recommend that Inner Spirit shareholders vote in favour of the Transaction. The transaction is expected to close early in the third quarter of 2021. Echelon Capital Markets, financial advisor to Inner Spirit, has provided a fairness opinion to the Board of Directors of Inner Spirit. ATB Capital Markets is acting as financial advisor to Sundial. McCarthy Tétrault LLP is acting as legal counsel to Sundial. Burstall LLP is acting as legal counsel to Inner Spirit.
お知らせ • Mar 16Sundial and SAF Group Announce Strategic Capital PartnershipSundial Growers Inc. announced they have entered into an agreement to form a 50/50 joint venture through a new corporation, SunStream Bancorp Inc. The Joint Venture will leverage a strategic financial and operational partnership to generate asymmetrically enhanced risk-return opportunities in the cannabis industry to provide exposure to a portfolio of attractive debt, equity and hybrid investments. The Joint Venture will focus on cannabis-related verticals, seeking both Canadian and international opportunities and investments. The Joint Venture's first mandate is the formation of a special opportunities fund with commitments from third party limited partners alongside an initial commitment from Sundial of $100 million. The Joint Venture expects to pursue additional potential mandates, including a Canadian SPAC and other investments.
お知らせ • Mar 03Sundial Growers Inc. to Report Q4, 2020 Results on Mar 17, 2021Sundial Growers Inc. announced that they will report Q4, 2020 results After-Market on Mar 17, 2021
お知らせ • Feb 18Sundial Regains Compliance with Nasdaq Minimum Bid Price RuleSundial Growers Inc. announced that the Nasdaq Stock Market ("Nasdaq") has confirmed that the Company has regained compliance with Nasdaq's minimum bid price requirements for continued listing on the Nasdaq Capital Market. As a result of the closing bid price of the Sundial's common shares having been at $1.00 per share or greater for at least ten consecutive business days, the Company has regained compliance with Nasdaq's Listing Rule, and the matter is now closed.
お知らせ • Feb 04Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million.Sundial Growers Inc. has completed a Composite Units Offering in the amount of $100 million. Security Name: Series A Units Security Type: Equity/Derivative Unit Securities Offered: 100,000,000 Price\Range: $0.75 Security Name: Series B Units Security Type: Equity/Derivative Unit Securities Offered: 33,333,334 Price\Range: $0.7499 Transaction Features: Registered Direct Offering
お知らせ • Jan 12Sundial Growers Inc. Announces the Launch of Premium Concentrates Products Under Its Top Leaf BrandSundial Growers Inc. launched high-quality cannabis derivative products under the Top Leaf brand in response to rising consumer demands for solventless cannabis extracts. This most recent launch is consistent with Sundial's focus on premium inhalables, following branded retail offerings of flower, pre-roll and vape cartridges. Sundial has launched a bubble hash product under its Top Leaf brand and will launch other products such as pressed hash and live rosin with capabilities to expand future product offerings through different Sundial brands in the coming quarters. Solventless concentrates from Top Leaf brands are available for purchase in B.C. and Alberta, with plans to be available across the country in the coming months. The Top Leaf brand currently offers Pink Kush and Bubba in the bubble hash format. All Top Leaf concentrate products are produced from high-quality, single-strain, fresh-frozen flower that is produced to preserve its terpene and cannabinoid profile. There are no additives, no fillers and no artificial flavors added to the products. Sundial plans on providing additional offerings in the first quarter of 2021 including Top Leaf's Oregon Golden Goat bubble hash and Grasslands' Sativa & Indica hash.
お知らせ • Jan 01Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million.Sundial Growers Inc. (NasdaqCM:SNDL) acquired Senior Secured Loans of Zenabis Investments Ltd for CAD 58.9 million on December 30, 2020. Pursuant to the terms of the Senior Loan, Zenabis will also pay Sundial a royalty based on quarterly sales revenue from its medical, recreational and wholesale cannabis lines net of value added or sales taxes which will be payable each fiscal quarter as follows 3.5% of Net Cannabis Revenue where Net Cannabis Revenue does not exceed CAD 25 million, 3.0% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 25 million but not CAD 30 million, 2.5% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 30 million but not CAD 37.5 million; and 2.0% of Net Cannabis Revenue where Net Cannabis Revenue exceeds CAD 37.5 million. Consideration was funded from Sundial's available cash reserves totaling $110 million prior to the acquisition's closing. Sundial Growers Inc. (NasdaqCM:SNDL) completed the acquisition of Senior Secured Loans of Zenabis Investments Ltd on December 30, 2020.
お知らせ • Dec 29Sundial Announces Concentrates Licence Agreement with Simply SolventlessSundial Growers Inc. announced that it has entered into a licence agreement with Simply Solventless Concentrates Ltd. for the processing and manufacturing of a suite of solventless cannabis concentrates products by Sundial in its Rocky View facility using SSC's intellectual property. The Agreement will enable Sundial to utilize its Rocky View asset, while enhancing its focus on producing premium inhalables. The new agreement also provides the Company the opportunity to leverage SSC's knowledge and expertise regarding concentrates manufacturing with an expanded line of products. Under the Agreement, SSC will receive a royalty on the sale of products manufactured using the SSC brand and technology. SSC will supply the non-cannabis materials to produce SSC concentrate products, in addition to paying Sundial a monthly administration fee. A minimum of 75% of the cannabis materials required for the processing and manufacturing of SSC products will be cultivated by Sundial unless such inventory is unavailable. Sundial expects to scale the distribution of SSC products across the country, with the first SSC products targeted to be in stores in the second quarter of 2021. With SSC's support, Sundial will utilize its craft at scale approach to produce and package the cannabis concentrate products, while leveraging its established sales and distribution infrastructure to get the products to market with speed and scale.
お知らせ • Dec 13Sundial Growers Transfers Listing to Extend Regaining Compliance PeriodOn December 11, 2020, Sundial Growers Inc. announced that it has received approval to transfer the listing of its common shares to the Nasdaq Capital Market. The Company had sought the transfer to take advantage of the additional 180 calendar day compliance period offered on the Nasdaq Capital Market, which will extend the period that the Company has to regain compliance with Nasdaq's minimum bid price requirement. The transfer is expected to become effective on December 15, 2020. As previously reported, the Company was notified by Nasdaq on May 12, 2020 that the bid price for its common shares was not in compliance with the Nasdaq minimum bid price requirement. At that time, the Company had until December 28, 2020 to regain compliance. The anticipated extension will allow the Company to regain compliance if for a minimum of 10 consecutive business days before June 26, 2021 the bid price for the Company's common shares closes at or above $1.00 per share. The Company intends to monitor the closing bid price of its common shares and has given written assurance to Nasdaq that it will, if necessary, implement available options to regain compliance with the minimum bid price requirement, including a reverse stock split.
Is New 90 Day High Low • Dec 01New 90-day high: €0.60The company is up 138% from its price of €0.25 on 02 September 2020. The German market is up 3.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Pharmaceuticals industry, which is up 1.0% over the same period. According to the Simply Wall St valuation model, the estimated intrinsic value of the company is per share.
Analyst Estimate Surprise Post Earnings • Nov 12Revenue misses expectationsRevenue missed analyst estimates by 43%. Over the next year, revenue is forecast to grow 36%, compared to a 3.3% growth forecast for the Pharmaceuticals industry in Germany.
Reported Earnings • Nov 12Third quarter 2020 earnings released: CA$0.53 loss per shareThe company reported a soft third quarter result with weaker revenues and control over expenses, though losses reduced. Third quarter 2020 results: Revenue: CA$12.9m (down 62% from 3Q 2019). Net loss: CA$71.4m (loss narrowed 27% from 3Q 2019).
お知らせ • Nov 10Sundial Growers Inc. Enters into Sales and Distribution Agreement with Choklat IncSundial Growers Inc. announced that it has entered into a sales and distribution agreement with Choklat Inc. The new collaboration between the two Alberta-based companies provides Sundial the opportunity to continue to expand its product portfolio and enter the edible market. As part of the contractual arrangement, Sundial and Choklat will launch a cannabis-infused confectionary brand, offering a selection of chocolate bars, drinking chocolate and infused sugar, all containing 10 milligrams of THC, the highest amount legal to sell in a single edible serving in Canada. Both companies expect to scale the collaboration across the country with first product targeting to be in-stores ahead of the holiday season in Alberta. Under the terms of the Agreement, Choklat will produce and package the products and Sundial will use its sales and distribution infrastructure to get the product on retailers' shelves. This agreement will enable both companies to capitalize on what they do best, which is produce conventional chocolate products for Choklat and produce premium cannabis products for Sundial. Choklat has a proven track record of producing craft chocolate confections, using the best quality ingredients. Choklat products are currently available in 110 groceries stores across Alberta and is producing its cannabis-infused confections in its 6,000 square-foot facility located in Calgary, Alberta. Sundial will ensure rigorous testing protocols are in place to guarantee the high-quality products its consumers are used to, as well as using only cannabis products with no fillers, additives or artificial flavouring.
お知らせ • Oct 30Sundial Growers Inc. to Report Q3, 2020 Results on Nov 11, 2020Sundial Growers Inc. announced that they will report Q3, 2020 results at 5:00 PM, Eastern Standard Time on Nov 11, 2020
お知らせ • Oct 06+ 1 more updateDavid Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million.David Ball, together with the senior management team of Bridge Farm Nurseries and Artemis Growth Partners reached an agreement to acquire Bridge Farm Nurseries Limited from Sundial Growers Inc. (NasdaqGS:SNDL) for CAD 90 million on May 15, 2020. As consideration for the Bridge Farm Disposition, buyer will (i) assume CAD 45 million of debt under Sundial's existing CAD 115 million term debt facility, (ii) assume the contingent consideration liabilities related to the remaining earn-out and additional share obligations under the original Bridge Farm acquisition agreement, dated as of July 2, 2019, and (iii) cancel approximately 2.7 million of Sundial common shares currently held by certain members of buyer. Sundial will not receive any cash consideration in connection with the transaction. The consideration is subject to some adjustment. The transaction was backed by Artemis Growth Partners. Following completion of the deal David Ball, a partner at Artemis Growth Partners, will re-join Bridge Farm as director of and advisor to the business. The Bridge Farm Disposition is subject to standard closing conditions and is further conditioned on Sundial restructuring the remaining CAD 70 million under its Term Debt Facility and entering into a new syndicated credit agreement with the Company's senior lenders on or before June 1, 2020. Upon termination buyer will pay CAD 1 million to seller as a termination fee. Closing is subject to the following conditions-a) each of the Fundamental Warranties given in favour of the Buyer pursuant to this Agreement; and the Warranties under Schedule 2, if so given in favour of the Buyer on the Closing Date, should be true and correct in all respects on the Closing Date and the Seller shall have executed and delivered to the Buyer a certificate confirming that the Fundamental Warranties in this Agreement and the Warranties under paragraph 30 of Part 2 of Schedule 2 are given on that basis b) the Seller should have performed, fulfilled and complied, and shall have caused the Group Entities to perform, fulfill and comply, with all of the obligations, covenants and conditions of this Agreement to be performed c) the Seller shall deliver to the Buyer within 5 Business Days before Closing its balance sheet evidencing its solvency d) no written notice having been received by the Parties of any legal or regulatory action, which would lead to termination of the transaction and there should be no injunction in effect against Closing entered by a court of competent jurisdiction against buyer and seller. e) David Ball and the management team should have secured unconditional funding of CAD 45 million from SAF and agreed the terms of the SAF Facility Deeds of Novation with SAF and the Seller and received consent from the Seller’s Guarantors Banks in respect of the matters contemplated in this Agreement. f) the Buyer shall have received written consent in a form reasonably satisfactory to SAF. g) Buyer Warranties made in favour of the Seller pursuant to this Agreement shall have been true and correct in all material respects on the date of this agreement and the Buyer have performed, fulfilled and complied with all of the obligations, covenants and conditions of this Agreement to be performed. h) the Seller shall have agreed the terms of the SAF Facility Deeds of Novation with SAF and the Buyer. Clearwater International acted as financial advisor, KPMG acted as accountant, with Pierce Atwood and Gavin Cummings and Shaun McCabe of Browne Jacobson acted as legal advisor to the buyers in the transaction. Robert Brant of Mccarthy Tetrault acted as legal advisor for Sundial Growers. Davies Ward Phillips & Vineberg acted as legal advisor for Artemis Growth Partners.
お知らせ • Aug 21Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million.Sundial Growers Inc. has completed a Composite Units Offering in the amount of $20.048572 million. Security Name: Series A Units Security Type: Equity/Derivative Unit Securities Offered: 25,820,000 Price\Range: $0.5 Discount Per Security: $0.03 Security Name: Series B Units Security Type: Equity/Derivative Unit Securities Offered: 14,280,000 Price\Range: $0.4999 Discount Per Security: $0.029994 Transaction Features: Registered Direct Offering
お知らせ • Aug 18Sundial Growers Inc. announced that it has received $18 million in fundingOn June 8, 2020, Sundial Growers Inc. (NasdaqGS:SNDL) closed the transaction. The transaction included participation from institutional investors. The conversion price of the notes is subject to adjustment in the event the company sells shares of common stock or common stock equivalents for less than $1 per share in the future, subject to customary excluded issuances. The company also issued warrants to purchase 14,457,059 shares at an exercise price of $0.9338 per warrant. The warrants will expire 3.5 years from the date that the underlying shares become freely tradable.
お知らせ • Jul 31Sundial Growers Inc. to Report Q2, 2020 Results on Aug 13, 2020Sundial Growers Inc. announced that they will report Q2, 2020 results at 5:00 PM, Eastern Standard Time on Aug 13, 2020
